Literature DB >> 7439971

Adherence of Streptococcus salivarius HB and HB-7 to oral surfaces and saliva-coated hydroxyapatite.

A H Weerkamp, B C McBride.   

Abstract

We compared the binding of Streptococcus salivarius HB and the mutant HB-7 to oral surfaces in vivo. Mutant HB-7 does not aggregate with saliva nor does it bind to buccal epithelium, but it does retain its ability to coaggregate with Veillonella and Fusobacterium. At 1 h after inoculation into the oral cavity of six volunteers, significantly more S. salivarius HB than HB-7 cells were found adhering to the buccal mucosa (P < 0.05) and to a cleaned tooth surface (P < 0.01); there was no significant difference in the numbers adhering to the tongue. The ratio of HB to HB-7 on the tongue increased in samples taken 1, 3, and 9 days after inoculation. The average time required to clear the mutant HB-7 from the oral cavity was 7 days, whereas that for the parent HB was greater than 20 days, and in some cases strain HB was still present 3 months after its inoculation. A representative S. salivarius serotype II strain, designated T3, behaved similarly to mutant HB-7 with respect to its adherence to the buccal mucosa. Strain HB adhered better to hydroxyapatite treated with human saliva than mutant HB-7; both strains adhered in similar numbers to untreated hydroxyapatite. Hydroxyapatite treated with rat saliva bound less HB than hydroxyapatite treated with human saliva, corresponding to the lower aggregating activity of rat saliva. Extraction of saliva with aggregating strains of S. salivarius reduced the ability of saliva to mediate attachment of strain HB to hydroxyapatite.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439971      PMCID: PMC551290          DOI: 10.1128/iai.30.1.150-158.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins.

Authors:  R C Williams; R J Gibbons
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  THE SOURCE OF SALIVARY BACTERIA.

Authors:  R J GIBBONS; B KAPSIMALIS; S S SOCRANSKY
Journal:  Arch Oral Biol       Date:  1964 Jan-Feb       Impact factor: 2.633

3.  Parameters that effect the adherence of Streptococcus salivarius to oral epithelial surfaces.

Authors:  R J Gibbons; J Van Houte; W F Liljemark
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

4.  Interbacterial aggregation of plaque bacteria.

Authors:  R J Gibbons; M Nygaard
Journal:  Arch Oral Biol       Date:  1970-12       Impact factor: 2.633

5.  Adherence as an ecological determinant for streptococci in the human mouth.

Authors:  J Van Houte; R J Gibbons; A J Pulkkinen
Journal:  Arch Oral Biol       Date:  1971-10       Impact factor: 2.633

6.  Antigenic components of the cell wall of Streptococcus salivarius.

Authors:  E A Montague; K W Knox
Journal:  J Gen Microbiol       Date:  1968-12

7.  Saliva-induced aggregation of oral streptococci.

Authors:  S Kashket; C G Donaldson
Journal:  J Bacteriol       Date:  1972-12       Impact factor: 3.490

8.  In vitro attachment of streptococci to the tooth surface.

Authors:  D Orstavik; F W Kraus; L C Henshaw
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

9.  Streptococcus mutans dextransucrase: requirement for primer dextran.

Authors:  G R Germaine; A M Chludzinski; C F Schachtele
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

10.  Dissociation of plaque formation from glucan-induced agglutination in mutants of Streptococcus mutans.

Authors:  M L Freedman; J M Tanzer
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  11 in total

1.  Hydroxyapatite adherence as a means to concentrate bacteria.

Authors:  E D Berry; G R Siragusa
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

2.  Adherence of oral streptococci to salivary glycoproteins.

Authors:  P A Murray; A Prakobphol; T Lee; C I Hoover; S J Fisher
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.

Authors:  K Komiyama; B F Habbick; S K Tumber
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

4.  Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.

Authors:  Tomas Fiedler; Catur Riani; Dirk Koczan; Kerstin Standar; Bernd Kreikemeyer; Andreas Podbielski
Journal:  Appl Environ Microbiol       Date:  2012-12-14       Impact factor: 4.792

5.  Role of interbacterial adherence in colonization of the oral cavities of gnotobiotic rats infected with Streptococcus mutans and Veillonella alcalescens.

Authors:  B C McBride; J S Van der Hoeven
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

6.  Cell wall-associated protein antigens of Streptococcus salivarius: purification, properties, and function in adherence.

Authors:  A H Weerkamp; T Jacobs
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Relationship of cell surface morphology and composition of Streptococcus salivarius K+ to adherence and hydrophobicity.

Authors:  A H Weerkamp; H C van der Mei; J W Slot
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

8.  Streptococcus salivarius strains carry either fibrils or fimbriae on the cell surface.

Authors:  P S Handley; P L Carter; J Fielding
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

9.  Whole, submandibular, and parotid saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  K Komiyama; B F Habbick; S K Tumber
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Adherence of Streptococcus sanguis to saliva-coated hydroxyapatite: evidence for two binding sites.

Authors:  E J Morris; B C McBride
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.